Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | BCL3 |
| Upstream (Parents) |
|---|
| (<<) CASP7 → BCL3 |
| (<<) DUSP5 → BCL3 |
| (<<) EGF → BCL3 |
| (<<) EIF4E → BCL3 |
| (<<) ENTPD7 → BCL3 |
| (<<) ERBB2 → BCL3 |
| (<<) GPNMB → BCL3 |
| (<<) GSTM3 → BCL3 |
| (<<) MT3 → BCL3 |
| (<<) PLOD2 → BCL3 |
| (<<) RHOB → BCL3 |
| (<<) STAT3 → BCL3 |
| (<<) TMEM158 → BCL3 |
| (<<) TNFAIP3 → BCL3 |
| Downstream (Children) |
|---|
| BCL3 → GNAI3 (>>) |
| BCL3 → KLK3 (>>) |
| BCL3 → NAB2 (>>) |
| BCL3 → TTC9 (>>) |
